EMS runs for suspected opioid overdose: Implications for surveillance and prevention

Prehospital Emergency Care

Volumn 17, Issue 3, 2013, Pages 317-329

  Knowlton, Amy ^a   Weir, Brian W ^a   Hazzard, Frank ^b   Olsen, Yngvild ^c,d,e   McWilliams, Junette ^a   Fields, Julie ^a,d   Gaasch, Wade ^b,f  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b Baltimore City Fire Department   (United States)

^c Baltimore Substance Abuse Systems   (United States)

^d Institutes for Behavior Resources Inc   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Emergency medical services; Epidemiology; Heroin opiate opioid abuse; Narcan naloxone; Overdose

Indexed keywords

NALOXONE; NARCOTIC ANALGESIC AGENT; NARCOTIC ANTAGONIST;

DRUG OVERDOSE; EMERGENCY HEALTH SERVICE; FEMALE; HUMAN; INCIDENCE; MALE; RETROSPECTIVE STUDY; RISK FACTOR; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME; UNITED STATES; UTILIZATION; ADDICTION; ARTICLE; UTILIZATION REVIEW;

ANALGESICS, OPIOID; BALTIMORE; DRUG OVERDOSE; EMERGENCY MEDICAL SERVICES; FEMALE; HUMANS; INCIDENCE; MALE; NALOXONE; NARCOTIC ANTAGONISTS; RETROSPECTIVE STUDIES; RISK FACTORS; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 84878843916     PISSN: 10903127     EISSN: 15450066     Source Type: Journal    
DOI: 10.3109/10903127.2013.792888     Document Type: Article

References (45)

1. Substance Abuse and Mental Health Services Administration (SAMHSA), Office of Applied Studies. National Survey on Drug Use and Health Report: Trends in Nonmedical Use of Prescription Pain Relievers: 2002 to 2007. Rockville, MD: SAMHSA, February 5, 2009.
2. Kochanek KD, Xu J, Murphy SL, et al. Deaths: final data for 2009. National Vital Statistics Reports;60(3). Hyattsville, MD: National Center for Health Statistics, 2012.
3. Substance Abuse and Mental Health Services Administration (SAMHSA), Office of Applied Studies. Results from the 2007 National Survey on Drug Use and Health: National Findings (NSDUH Series H-34, DHHS Publication No. SMA 08-4343). Rockville, MD: SAMHSA, 2008.
4. Smyth B, Hoffman V, Fan J, Hser YI. Years of potential life lost among heroin addicts 33 years after treatment. Prev Med. 2007;44:369-74. (Pubitemid 46550676)
5. Coben JH, Davis SM, Furbee PM, Sikora RD, Tillotson RD, Bossarte RM. Hospitalizations for poisoning by prescription opioids, sedatives, and tranquilizers. Am J Prev Med. 2010;38:517-24.
6. Hall AJ, Logan JE, Toblin RL, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA. 2008;300:2613-20.
7. Schneider MF, Bailey JE, Cicero TJ, et al. Integrating nine prescription opioid analgesics and/or four signal detection systems to summarize statewide prescription drug abuse in the United States in 2007. Pharmacoepidemiol Drug Saf. 2009;18:778-90.
8. Cepeda MS, Fife D, Chow W, Mastrogiovanni G, Henderson SC. Assessing opioid shopping behaviour: a large cohort study from a medication dispensing database in the US. Drug Saf. 2012;35:325-34.
9. Substance Abuse and Mental Health Services Administration (SAMHSA), Office of Applied Studies. Drug Abuse Warning Network 2006: National Estimates of Drug-Related Emergency Department Visits. DAWN Series D-30, DHHS Publication No. (SMA) 08-4339. Rockville, MD: SAMHSA, 2008.
10. Merchant RC, Schwartzapfel BL, Wolf FA, Li W, Carlson L, Rich JD. Demographic, geographic, and temporal patterns of ambulance runs for suspected opiate overdose in Rhode Island, 1997-2002. Subst Use Misuse. 2006;41:1209-26. (Pubitemid 44155100)
11. Dietze P, Fry C, Sunjic S, et al. Using ambulance attendances to recruit people who have experienced non-fatal heroin overdose. Drug Alcohol Depend. 2002;67:99-103. (Pubitemid 34615932)
12. Seidler D, Schmeiser-Rieder A, Schlarp O, Laggner AN. Heroin and opiate emergencies in Vienna: analysis at the municipal ambulance service. J Clin Epidemiol. 2000;53:734-41. (Pubitemid 30609627)
13. Wampler DA, Molina DK, McManus J, Laws P, Manifold CA. No deaths associated with patient refusal of transport after naloxone-reversed opioid overdose. Prehosp Emerg Care. 2011;15:320-4.
14. Buajordet I, Naess AC, Jacobsen D, Brors O. Adverse events after naloxone treatment of episodes of suspected acute opioid overdose. Eur J Emerg Med. 2004;11:19-23.
15. Vilke GM, Buchanan J, Dunford JV, Chan TC. Are heroin overdose deaths related to patient release after prehospi-tal treatment with naloxone? Prehosp Emerg Care. 1999;3: 183-6. (Pubitemid 29356339)
16. Coffin PO, Tracy M, Bucciarelli A, Ompad D, Vlahov D, Galea S. Identifying injection drug users at risk of nonfatal overdose. Acad Emerg Med. 2007;14:616-23. (Pubitemid 46929086)
17. Dietze P, Jolley D, Cvetkovski S, Cantwell K, Jacobs I, Indig D. Characteristics of non-fatal opioid overdoses attended by ambulance services in Australia. Aust N Z J Public Health. 2004;28:569-75. (Pubitemid 40305503)
18. Kerr D, Kelly AM, Dietze P, Jolley D, Barger B. Randomized controlled trial comparing the effectiveness and safety of in-tranasal and intramuscular naloxone for the treatment of suspected heroin overdose. Addiction. 2009;104:2067-74.
19. Evans JL, Tsui JI, Hahn JA, Davidson PJ, Lum PJ, Page K. Mortality among young injection drug users in San Francisco: a 10-year follow-up of the UFO study. Am J Epidemiol. 2012;175:302-8.
20. Gilson AM. The concept of addiction in law and regulatory policy related to pain management: a critical review. Clin J Pain. 2010;26:70-7.
21. Pollini RA, McCall L, Mehta SH, Vlahov D, Strathdee SA. Non-fatal overdose and subsequent drug treatment among injection drug users. Drug Alcohol Depend. 2006;83:104-10. (Pubitemid 43795468)
22. Togia A, Sergentanis TN, Sindos M, et al. Drug abuse-related emergency calls: a metropolis-wide study. Prehosp Disaster Med. 2008;23:36-40.
23. Tracy M, Piper TM, Ompad D, et al. Circumstances of witnessed drug overdose in New York City: implications for intervention. Drug Alcohol Depend. 2005;79:181-90. (Pubitemid 40942108)
24. Baca CT, Grant KJ. What heroin users tell us about overdose. J Addict Dis. 2007;26(4):63-8.
25. Maryland Institute for Emergency Medical Services Systems. The Maryland Medical Protocols for Emergency Medical Services Providers. MIEMSS; 2008:348. Available at: http://www.miemss.org/home/LinkClick.aspx?fileticket= PcFzAVnOA4M%3d&tabid=106&mid=537. Accessed May 9, 2013.
26. Office of Epidemiology and Planning. Intoxication Deaths Associated with Drugs of Abuse or Alcohol. 2009 Final Report. Baltimore City, MD: Baltimore City Health Department, and Baltimore Substance Abuse Systems, July 2011. Available at: http://www.baltimorehealth.org/info/DOA%20Final%20 Report%202009-Final.pdf. Accessed May 9, 2013.
27. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Drug Abuse Warning Network: Area profiles of drug-related mortality. DHHS Publication No. (SMA). SMA10-4473. Rockville, MD: SAMHSA, 2008.
28. Yacoubian GS, Hsu M, Wish ED. Estimating the Need for Substance Abuse Treatment in Maryland: An Update of Reuter et al. (1998) College Park, MD: Center for Substance Abuse Research (CESAR), University of Maryland, 2002.
29. Friedman SR, Tempalski B, Cooper H, et al. Estimating numbers of injecting drug users in metropolitan areas for structural analyses of community vulnerability and for assessing relative degrees of service provision for injecting drug users. J Urban Health. 2004;81:377-400. (Pubitemid 39128276)
30. Maryland Institute for Emergency Medical Services Systems. EMAIS User Manual 3.0. Baltimore, MD: MIEMSS, 21. Available at: http://www.miemss.org/home/ LinkClick. aspx?fileticket=AZFED0if7jQ%3d&tabid=54. Accessed April 14, 2013.
31. U.S. Census Bureau. Preliminary Annual Estimates of the Resident Population for the United States, Regions, States, and Puerto Rico: April 1, 2000 to July 1, 2010 (NST-PEST2010-01). Available at: http://www.census.gov/ popest/research/eval-estimates/eval-est2010.html. Accessed May 9, 2013.
32. Microsoft Corporation. Microsoft Office Access 11.5. Redmond, WA, 2003.
33. IBM Corporation. SPSS 19.0, Armonk, NY.
34. StataCorp. Stata Statistical Software: Release 10.1. College Station, TX.
35. Edwards JH. The recognition and estimation of cyclic trends. Ann Hum Genet. 1961;25:83-7.
36. Substance Abuse and Mental Health Services Administration. State Estimates of Substance Use and Mental Disorders from the 2008-2009 National Surveys on Drug Use and Health, NSDUH Series H-40; DHHS Publication No. (SMA) 11-4641. Rockville, MD: SAMHSA, 2011.
37. Phillips DP, Christenfeld N, Ryan NM. An increase in the number of deaths in the United States in the first week of the month-an association with substance abuse and other causes of death. N Engl J Med. 1999;341:93-8. (Pubitemid 29314241)
38. Hoffman JR, Schriger DL, Luo JS. The empiric use of naloxone in patients with altered mental status: a reappraisal. Ann Emerg Med. 1991;20:246-52.
39. Institute of Medicine (IOM). Emergency Medical Services: At the Crossroads. Washington, DC: National Academies Press, 2007.
40. Barnett PG, Masson CL, Sorensen JL, Wong W, Hall S. Linking opioid-dependent hospital patients to drug treatment: health care use and costs 6 months after randomization. Addiction. 2006;101:1797-804. (Pubitemid 44899702)
41. Tobin KE, Sherman SG, Beilenson P, Welsh C, Latkin CA. Evaluation of the Staying Alive programme: training injection drug users to properly administer naloxone and save lives. Int J Drug Policy. 2009;20:131-6.
42. Sherman SG, Gann DS, Tobin KE, Latkin CA, Welsh C, Bielenson P. "The life they save may be mine": diffusion of overdose prevention information from a city sponsored programme. Int J Drug Policy. 2009;20:137-42.
43. Baca CT, Grant KJ Take-home naloxone to reduce heroin death. Addiction. 2005;100:1823-31. (Pubitemid 41775207)
44. Enteen L, Bauer J, McLean R, et al. Overdose prevention and naloxone prescription for opioid users in San Francisco. J Urban Health. 2010;87:931-41.
45. George S, Boulay S, Begley D. 'I saved a life': a heroin addict's reflections on managing an overdose using 'take home nalox-one'. BMJ Case Rep. Sep 7;2010.